Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2008 October;49(5) > The Journal of Cardiovascular Surgery 2008 October;49(5):559-63

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

THE JOURNAL OF CARDIOVASCULAR SURGERY

A Journal on Cardiac, Vascular and Thoracic Surgery


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,179


eTOC

 

  RECENT ADVANCES IN RENAL ARTERY STENTING


The Journal of Cardiovascular Surgery 2008 October;49(5):559-63

Copyright © 2008 EDIZIONI MINERVA MEDICA

language: English

Invasive treatment for renovascular disease. A twenty year experience from a population based registr

Bergqvist D. 1, Björck M. 1, Lundgren F. 2, Troëng T. 3

1 Department of Surgical Sciences Section of Surgery Uppsala University Hospital Uppsala, Sweden 2 Department of Vascular Surgery University Hospital, Linköping, Sweden 3 Department of Surgery Blekinge Hospital, Karlskrona, Sweden


PDF  


Aim. To analyze time trends in invasive treatment of renovascular disease in one country.
Method. Data have been analyzed from registrations in the Swedish Vascular Registry.
Results. Invasive treatment for renovascular disease contributes around 1% of all vascular surgery within the Swedish Vascular Registry. Over the twenty-year period 1987-2006 the population-based frequency of invasive treatment for renovascular disease has increased; 1 597 procedures have been registered with an increase over time. The age of the treated patients has increased over the period (P<0.001). There has been a shift from open to endovascular procedure and from isolated percutaneous transluminal renal angioplasty (PTRA) to PTRA combined with a stent. Complications and mortality are significantly higher in patients undergoing open reconstruction (P<0.01). One year follow-up is incomplete and long-term results are therefore not possible to evaluate through registry-data only.
Conclusion. Using nation-wide registry data it is possible to analyze time-trends also concerning rare diseases or interventions. The changing pattern toward endovascular treatment of renovascular disease is obvious. Follow-up data at one year are incomplete.

top of page

Publication History

Cite this article as

Corresponding author e-mail